← Signals · Healthcare · TSXV
$MRVL
Marvel Biosciences Corp.
Signal as of N/A  ·  90-day rolling window  ·  Biotechnology & Life Sciences
Confluence Score
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 47% of the time (avg +6.8% over 90 days, 105 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
Confluence Score
Insider Activity (90d)
3
4 buyers  ·  $508K  ·  open-market only
Current Price
$0.17
CAD  ·  5-min cache
Market Cap
$11M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 43% hit rate · -5.4% alpha vs XIU.TO · 21 closed signals Track Record →
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:MRVL
Insider Transactions
90-day window  ·  3 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
May 19, 2026 Smallbone, Sidney Randall Other Buy 16,667 $0.15 +13.3%  · 53d $3K
May 19, 2026 Johnson, Neil Allan Other Buy 16,667 $0.15 +13.3%  · 53d $3K
May 19, 2026 Pedram, Babak Comp. Grant Buy 16,667
Score uses open-market buys only  ·  0 open-market  ·  3 plan / compensation shown but not scored  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 20 30 4 unique buyers
Buy/sell ratio 20 50% buys (3B / 3S)
Dollar value 25 $508K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 0 100
Unlock Component Detail — CAD $29/mo
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for MRVL.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Jun 30, 2026
Shares short
29,402
Net change
+25,598 (+672.9%)
Short interest rose 673% since the prior report.
History
Jun 30: 29,402
Jun 15: 3,804
May 31: 24,674
May 15: 689
Apr 30: 208
Apr 15: 1,959
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Boardroom Connections
2 insiders also active elsewhere
Insider Other boards Also an insider at
Nijjar, Harpreet 2 PEX, BPAG
Johnson, Neil Allan 1 TTI
People who file as insiders here and at other TSX/TSXV companies (number in brackets = that company's Confluence Score). A well-connected insider taking a seat at a new junior can be an early tell. Matched by name across SEDI filings; funds and 10%+ holders excluded.
Government Grants & Funding
1 federal award  ·  $47K total
Program / Agreement Department Amount Start
Industrial Research Assistance Program Contribution National Research Council Canada $47K Jan 2026
Federal grants & contributions disclosed by the Government of Canada (Proactive Disclosure), matched to this issuer by legal name. Government funding can be a pre-revenue validation and capital signal. Display-only context, not a Confluence Score input.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.